HUBS.NYSEHubspot INC

Form 4: HubSpot's Chief Legal Officer, Alyssa Harvey Dawson, Executes Stock Sale Under 10b5-1 Plan

Sentiment:

SEC Form 4


Alyssa Harvey Dawson, Chief Legal Officer of HubSpot, sold 384 shares of common stock at $650 per share under a pre-arranged 10b5-1 trading plan.

Summary

  • On November 7, 2024, Alyssa Harvey Dawson, the Chief Legal Officer of HubSpot Inc., sold 384 shares of common stock.
  • The sale was executed at a price of $650 per share.
  • This transaction was conducted under a pre-arranged 10b5-1 trading plan adopted on February 16, 2024.
  • Following the transaction, Ms. Dawson directly owns 8,176 shares of HubSpot common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment. This is a standard disclosure of a pre-planned stock sale by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Future Outlook

There is no future outlook provided in this document.

Industry Context

This is a routine disclosure of an insider stock transaction. It's common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of insider trading. The sale itself doesn't necessarily indicate a negative outlook on the company.

Comparison to Industry Standards

  • Executive stock sales are a common occurrence in publicly traded companies.
  • The use of 10b5-1 trading plans is a standard practice to ensure compliance with insider trading regulations.
  • Comparing the size and frequency of these sales to those of executives at comparable SaaS companies like Salesforce, Adobe, or Shopify would provide a better understanding of whether this transaction is unusual.

Stakeholder Impact

  • The sale of shares by a company executive can sometimes be perceived negatively by shareholders, although in this case it is less likely due to the 10b5-1 trading plan.

Key Dates

DateDescription
02/16/2024Date the 10b5-1 trading plan was adopted.
11/07/2024Date of the stock sale transaction.
11/08/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.